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The use of herbal medicine is increasingly finding more relevance today, especially with the recognition that we are 
facing more challenges in the treatment of some medical conditions such as diabetes and cancer. To date, there are 
not many publications or records on the traditional herbal medicine use among the various Kenyan communities 
despite the widespread use. There is therefore an urgent need to document traditional medicines in Kenya for future 
reference and research. 
The main objective of this review is to examine the current state of traditional herbal medicine practise in Kenya, the 
challenges facing the sector and the possible solutions to streamline the practice and maximize on the benefits. The 
method adopted in this research involved the analysis of the available records on herbal medicine in Kenya from 
various sources including internet and the available books. This information was then compared with those in other 
countries with established systems in order to establish the existing inadequacies. The various efforts to document 
herbal medicine incorporate into mainstream healthcare and the legal framework was also reviewed. 
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1. Introduction and Review 
Ethnopharmacology may be broadly defined as the 
study of the indigenous drugs from plants and animals 
used in past and present cultures (Bruhn et al, 1982). 
The practice of traditional medicine (TM) is as old as 
the human race itself (Vickers et al, 2001). Several 
drugs have been derived directly or indirectly from 
plants including digoxin, taxol, vinblastine, nabilone and 
artemesin. It has been estimated that over 60% of the 
current anticancer and antihypertensive drugs are of 
plant origin (Cragg et al, 2005; Newman et al, 2003). 
Medicinal plants have therefore become important 
source of research and development of new drugs 
(Ebadi, 2006). Currently, many plants are being 
investigated for potential therapeutic effects including 
the Graviola plant which has shown evidence of 
anticancer activities (Torres et al, 2012).  
The World Health Organisation (WHO) estimates that 
up to 80% of the population in some developing 
countries use TM. In addition, trade in herbal medicine 
is gaining acceptance globally and is now a lucrative 
business generating lots of revenue. In sub-Saharan 
Africa, the traditional healers still play a major role in 
the provision of healthcare. This has been attributed in 
part to the unavailability of healthcare facilities and 
affordability (WHO, 2008; WHO, 2002).  
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The Kenyan situation is not any much different, and 
many communities especially from the poor rural areas 
still rely on herbal remedies. In addition, many Kenyans 
believe in the potency of herbal medicine, even when 
they can access modern medicine. In many cases they 
would choose to combine both herbal and modern 
medicine, especially if they are afflicted with chronic 
ailments such as HIV/AIDS, hypertension, infertility, 
cancer and diabetes (Nagata et al, 2011).  
Like most other African countries, Kenya has a large 
number of tribes and each has its own peculiar customs 
and beliefs. The use of herbal medicine is equally 
different among the communities. Despite this, most of 
the medications have not been documented and 
scientifically evaluated to determine their efficacy and 
dosage vis-à-vis the alleged indications by the 
practitioners. These medications have been in use for 
centuries and it is quite possible that they could possess 
some degree of potency, and can potentially be used in 
therapy of some of the current conditions. Hence there 
is need to identify these plant and document them for 
future reference and research (IEA, 2011a). 
Currently, there is little information regarding literature 
on the use of medicinal plants in Kenya, with only a few 
and far between authors having contributed. However, 
there are some few books that have been written on the 
subject (Dharani et al, 2010; Gachati, 1989; Gachati, 
2007; Kokwaro, 2009; Watt et al, 1962); including other 
reference books on use of the plants which may provide 
some valuable information for researchers (Beentje, 
1994; Blundell, 1992; Maundu, 1999). A number of 
authors have also published papers on the 
ethnobotanical plant use among the some select Kenyan 
communities (Bussmann et al, 2006; Heine et al, 1988; 
Jeruto et al, 2008; Jeruto et al, 2007; Johns et al, 1990; 
Keter et al, 2011; Lindsay, 1978; Nanyingi et al, 2008; 
Okello et al, 2009). In addition, there  are  some  
important databases which provide information on 
some Kenyan medicinal plants including the KENRIK 
database at the National Museums of Kenya (NMK; 
Prelude).  
However, the most encouraging bit is that there are 
several publications with regards to the products 
obtained from the extracts of these plants, with quite a 
number showing pharmaceutical activities and 
potential for the development of new pharmaceutical 
products (Irungu et a., 2012; Langat et al, 2012; 
Matheka et al, 2012). The development of a database 
containing information on both the ethnobotanical and 
the properties of the extracts from the plant is 
important for future research and development. 
Regulation 
The regulation of herbal medicine practise is still a 
major challenge in Africa (Madiba, 2010). Several Asian 
countries have incorporated herbal medical practice 
into their National Drug Policies, but this is yet to be 
effected in Kenya (Xiaorui, 2000). TM was officially 
recognized in the 1990’s and the patent law was revised 
to include TM in the 1999 (WHO, 2001). Since then, 
there have been little developments in the regulation of 
the TM practice in Kenya. Recently, a task force was 
constituted to draft the laws to regulate and practice 
with a view to incorporating the herbal practitioners in 
mainstream healthcare. However, this is still in 
formative stages as there are several challenges to be 
overcome (Mwangi, 2004; NCAPD, 2008). 
Currently, the Kenyan Pharmacy and Poisons Board 
(PPB) is involved in the registration of herbal and 
complementary products [the medicinal products that 
have been formulated in commercial manner] (PPB, 
2010). Most of these products are imported from Asia, 
with the bulk coming from India and China. The 
registration of herbalists is done by the Ministry of 
Social services, but in essence most of the traditional 
herbalists are not even aware of this, unless they are 
practicing in urban areas whereby the local authorities 
enforce the registration. Hence there are scant records 
on the actual number of practicing herbalists. In 
addition, there are several fake herbalists. The 
regulating authority should develop guidelines and legal 
framework for the registration of herbalists in order to 
streamline the herbal practice and protect the citizen 
from this type of herbalists. 
Sociocultural issues 
The practice of herbal medicine in Kenya, unlike Asia, 
has largely been considered primitive by the elite. Over 
the years, the practice of herbal medicine has been 
downgraded as a result of the introduction of 
conventional medicine that are available in more 
patient friendly (compliant) formulations such as 
syrups, capsules and tablets as opposed to traditional 
roots, barks and leaves which are often bitter to taste. In 
addition, the practice is also no longer a major income 
earner as it was previously. It has therefore been 
downgraded to poor and illiterate people (Thairu, 
1975). 
In most Kenyan communities, perhaps due to cultural 
reasons, the practice was considered a family affair and 
the practitioner would prefer to transfer the talent to 
one close relative. Unfortunately, most of the young 
people are not willing to take up the art for lack of 
financial gain, are engaged in other income generating 
activities, have trained in other professions, or are 
simply not interested as the practice as it is generally 
considered outdated (Lindsay, 1978; Nyamwaya, 1992). 
Sadly, most of these practitioners end up dying with 
their valuable knowledge that may probably have been 
used to treat some of the conditions that currently have 
no cure such as cancer. Indeed most of the “true” 
herbalists are now at advanced age, perhaps over 70 
years (Muchae, 2000). On the contrary, the Chinese 
traditional medicines were recorded and thanks to this 
we now have a leading cure of malaria from the 
wormwood (Atemesia annua spp.) that was used in 
China more than a thousand years ago (Hsu, 2006). 
However, due to the recent upsurge of some chronic 
conditions such as diabetes, asthma, infertility, cancer 
and HIV/AIDS that do not respond very well to 
conventional medicine, there has been considerable 
interest in traditional medicine in Kenya. This has led to 
the emergence of several “quack’’ traditional healers 
especially in urban areas who are out to fleece and 
make quick bucks from desperate patients.  Indeed, it is 
not easy to identify a genuine herbal practitioner in 
Kenya nowadays, especially in urban areas. Most have 
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put up adverts with claims that they can literally treat 
all known conditions, but for a fee (NCAPD, 2008). The 
genuine traditional healers tend to be more specific in 
their treatments, for example they may specialise in 
women’s diseases, children diseases, asthma and other 
conditions (Sindiga, 1995).  
Herb - drug interactions 
Several patients with chronic diseases often combine 
conventional medicine with TM. Herbal medicines like 
any other drugs are known to interact with 
conventional drugs through various mechanisms. The 
herbs may alter their pharmacokinetics leading to an 
increase or decrease in plasma concentrations, thus 
altering the therapeutic outcomes. The interactions may 
also lead to several other short or long term adverse 
effects (Chen et al, 2011; Hu et al, 2005; Izzo et al, 2009; 
Tsai et al, 2012). Despite this, to date there is little 
research that has been carried out to determine their 
active ingredients and document the potential 
interactions involving the Kenyan herbal products and 
prescription drugs. 
Deforestation 
The wanton destruction of forests in Kenya is of serious 
concern for Kenya’s biodiversity. Currently there are 
several non-governmental organizations (NGOs) that 
are actively involved in the conservation of forests 
including International Union for Conservation of 
Nature (IUCN), World Wide Fund for nature (WWF) and 
the Greenbelt Movement that was founded by the late 
Nobel laureate Wangari Maathai. The Kenyan forest 
cover has reduced drastically and now stands at about 
2.5% down from about 12.5% in the sixties mainly due 
to rapidly expanding population, illegal logging and 
acquisition of land for cultivation (FSK, 2008; KFWG, 
1999). This has had a major impact on the medicinal 
plants, like has happened in many other parts of the 
world. Indeed some of the species may have 
disappeared completely (Rukangira, 2001a; Shanley, 
2003). 
There is yet another form of commercial exploitation 
that targets the medicinal plants that have been 
identified to have direct medicinal uses. This practice is 
unlike that of early traditional herbalists who collected 
medicinal plants according to tradition ethics, and 
therefore protected the plants (Watt et al, 1962). An 
example of such a plant is the Prunus africana bark 
whose bark was discovered to be effective in the 
management of benign prostatic hyperplasia 35 years 
ago. The extract is formulated and sold as capsules 
(Pygeum africanum) by pharmaceutical companies 
mainly in Europe. This has led to increased harvesting 
to the extent that it was declared endangered by the 
Convention of International Trade in Endangered 
Species (CITES) in 1995 (K.M, 2003). Similarly, the 
sandalwood tree (Osyris lanceolata) has been illegally 
harvested for both medicinal and cosmetic purposes in 
Kenya and exported to Europe or Asia (WildlifeDirect, 
2009). Several other plants have been exploited for 
medicinal uses including Warburgia ugandensis, 
Pausinystalia johimbe (used as an aphrodisiac), Griffonia 
simplicifolia (mood disorders), and Harpagophytum 
procumbens [pain management] (Wamalwa et al, 2006).  
Uncontrolled harvesting of Mondia (Mondia whytei) 
locally referred to as “Mukombero’’, has been reported 
in Western Kenya. The local communities believe that 
its roots have aphrodisiac capabilities (RNW, 2011). 
Several Aloe species in Kenya have also been listed as 
threatened due to overexploitation for commercial 
activities (CITES, 2003).  
In order to address this problem, the recognition of 
medicinal plants and establishment of medicinal 
botanical gardens and farms may have to be undertaken 
in order to achieve sustainable utilization and 
conservation of the plants. The participation of the local 
communities is pivotal in this process. This has been 
tried in Egypt with some measure of success 
(Rukangira, 2001a). 
Research 
Research on TM is not very well co-ordinated in Kenya. 
The Kenyan universities and the Kenya Medical 
Research Institute (KEMRI) are currently undertaking 
some research in TM. Generally most of the research is 
academic, that is screening for active ingredients from 
the plant extracts for pharmacological and related 
activities. This is because of the fact that there is not 
much funding for the research on TM from the 
Pharmaceutical companies, unlike the Universities in 
the West. Indeed it is difficult to do research in most 
African countries owing to limited resources and 
specialized equipment. There have also been reports 
that some bioprospectors, both local and international 
have been individually collecting the medicinal plants 
from practising herbalists for purposes of research. In 
most cases, they do not reveal their findings to the 
herbalists who provided them with the samples 
(allAfrica, 2005; IEA, 2011b; Rukangira, 2001a). 
Modern research in herbal medicine is quite expensive. 
It usually involves a random selection of plants and 
screening them for any active ingredients, followed by 
biological assays for targeted activities such as 
antibacterial, anticancer and other groups (Farnsworth, 
1966). Natural Cancer Institute U.S.A (NCI) screened 
over 35,000 plant species for evidence of anticancer 
activity between 1960 and 1981. Some of the plants 
including taxol and campothecin showed some 
pharmacological activity (Boyd, 1995). However, this is 
a very expensive method and sometimes considered 
wasteful since the plants in question may have other 
important pharmacological activities other than the 
targeted activity (Fabricant et al, 2001).  
This kind of mass screening may not be applicable in 
most African countries owing to limited funds 
(Rukangira, 2001b). However, if there were 
documented records on the information from the plants 
and the conditions that the herbalists use, then it might 
provide an easier option for researchers in Africa. This 
is in terms of corroborating the extracts from the 
sample plants and the alleged medical uses or any other 
conditions. 
The most challenging step for any potential researcher 
of TM in Kenya is the collection of ethnomedical 
information. This is because there are so many fake 
practitioners, and the identification of “genuine’’ 
herbalists is not an easy task. In addition, there are 
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currently no reliable records of herbal practitioners. 
One might therefore quite easily collect information 
from fake practitioners who would readily provide the 
information in exchange of some little token. They 
exploit the old tradition practised in many Kenyan 
communities whereby one was expected to offer some 
token of appreciation upon treatment by a herbalist 
(NCAPD, 2008).  
Since most of the current practitioners operate within 
the rural areas, it is important for researchers to engage 
the opinion leaders who command the respect of their 
local communities. These include the provincial 
administration (local chiefs), religious leaders and local 
professionals such as teachers. This cadre of people 
would provide credible information about the genuine 
practising herbalists as well as the medical conditions 
by which they are known to treat. The use of 
inducements should be discouraged as much as possible 
as this would open way for the fake practitioners. 
Education is also very important in order to encourage 
the herbalists to provide the information without fear to 
other persons who are not members of their families. 
Educated close relatives of the herbalists may also be 
used to convince the herbalists on the need to provide 
the information. Renowned herbalists should be first 
approached and questionnaires may be used as a guide 
to select the eligible herbalists (IEA, 2011b). 
Where there is evidence that an herbalist may have 
actually treated some specific conditions such as 
infertility, some form of patenting of the plant products 
in the name of the practitioner may be encouraged in 
order to stimulate them to provide the information. The 
herbalists should also be requested to provide the 
samples for identification by botanists from local 
universities and other institutions such as the East 
African herbarium. Databases on this can then be 
developed for future research (Christian, 2009). 
2. Discussion  
It is clear that there is a lot of potential in Kenyan herbal 
medicine judging from the published laboratory results 
from the screening of the plant exudates that have been 
analysed in our various institutions. However, in as 
much as we are doing well on this, there is need to 
document the information from herbalists in order to 
provide a database for future research and potential for 
the development of new drugs. There are some genuine 
concerns arising from the realisation that the old 
generation that holds this knowledge is fast aging and 
the young generation do not seem to take much interest 
in advancing this knowledge. The rapid deforestation 
exacerbates the situation. The knowledge for the 
potential cures for diseases such as cancer may 
therefore be extinct before it is even discovered. This 
could be replicated in other sub-Saharan African 
countries, as there are no proper records in most of 
these countries. This will certainly not be an easy task 
owing to the costs involved, and the pharmaceutical 
industry may not be willing to fund since it may not 
provide immediate gains. However, in the long run this 
will provide a very useful reservoir for future research 
and development of new drugs. Databases on the 
ethnomedical information from every region of the 
country should be compiled with a view to the 
development of centralised records for ease of 
reference. The Universities, NGOs and perhaps WHO 
should take lead in this worthwhile project. 
3. Conclusion  
There is an urgent need to document information on 
traditional Kenyan herbal medicine because there are 
genuine concerns that this knowledge may be 
completely lost. There should also be development of 
legal frameworks to regulate the herbal practice in 
Kenya and possibility of incorporating herbal practise in 
mainstream health services as it has been successfully 
done in Asian countries. 
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